Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-02-22FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for Granules Pharmaceuticals' generic four-salt amphetamine combination (dextroamphetamine saccharat…
-
FDA approval · 2023-02-15FDA Approved: ATOMOXETINE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for a generic Atomoxetine product from Strides Pharma Science Limited, enabling market entry of …
-
FDA approval · 2023-02-07FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application from Sandoz Inc for a generic product containing four amphetamine salts (dextroamphetamine saccharat…
-
FDA approval · 2023-01-23FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved Granules Pharmaceuticals' generic combination amphetamine product containing dextroamphetamine saccharate, amphetamine aspartat…
-
FDA approval · 2023-01-19FDA Approved: ATOMOXETINE HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for atomoxetine hydrochloride from Apotex Corp., approving a generic version of the ADHD medication.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-12-28FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (XLCare Pharmaceuticals, Inc.)
FDA approved a supplemental application for methylphenidate hydrochloride from XLCare Pharmaceuticals, Inc., establishing a generic version …
-
FDA approval · 2022-12-20FDA Approved: ATOMOXETINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Atomoxetine (generic) submitted by Aurobindo Pharma Limited.
-
FDA approval · 2022-12-16FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories' supplemental application for methylphenidate hydrochloride (generic). This approval authorizes the manufac…
-
FDA approval · 2022-12-16FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Neolpharma, Inc.)
FDA approved a supplemental application for methylphenidate hydrochloride (Neolpharma, Inc.) under an ANDA, granting regulatory approval for…
-
FDA approval · 2022-11-30FDA Approved: MIXED SALTS OF A SINGLE ENTITY AMPHETAMINE PRODUCT XR — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for Mixed Salts of a Single Entity Amphetamine Product XR, a generic extended-release amphetamine pr…
-
FDA approval · 2022-10-14FDA Approved: DYANAVEL XR — Supplemental Application (NextWave Pharmaceuticals, Inc)
The FDA approved a supplemental application for DYANAVEL XR (amphetamine) filed by NextWave Pharmaceuticals, Inc., granting regulatory appro…
-
FDA approval · 2022-09-21FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (KVK-TECH, INC.)
FDA approved a supplemental application for methylphenidate hydrochloride from KVK-Tech, Inc., a generic stimulant used to treat attention-d…
-
FDA approval · 2022-09-16FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Camber Pharmaceutical Inc)
FDA approved Camber Pharmaceutical Inc.'s supplemental application for methylphenidate hydrochloride (generic) under an Abbreviated New Drug…
-
FDA approval · 2022-09-14FDA Approved: METHYLPHENIDATE HYDROCHLORIDE (LA) — Supplemental Application (Dr. Reddy's Laboratories Inc)
The FDA approved a supplemental application for methylphenidate hydrochloride (LA) from Dr. Reddy's Laboratories Inc. This action supports t…
-
FDA approval · 2022-09-06FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Cranbury Pharmaceuticals, LLC)
The FDA approved a supplemental application for methylphenidate hydrochloride (generic product) from Cranbury Pharmaceuticals, LLC. This app…
-
FDA approval · 2022-08-18FDA Approved: DEXTROAMPHETAMINE SULFATE — Original Application (Cranbury Pharmaceuticals, LLC)
FDA has approved Cranbury Pharmaceuticals' original application for a generic dextroamphetamine sulfate product. The approval covers its use…
-
FDA approval · 2022-08-16FDA Approved: XELSTRYM — Supplemental Application (Noven Therapeutics, LLC)
The FDA approved a supplemental application for XELSTRYM (dextroamphetamine) submitted by Noven Therapeutics, LLC.
-
FDA approval · 2022-07-08FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Original Application (Lannett Company, Inc.)
FDA approved Lannett's generic combination of four amphetamine salts (dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine…
-
FDA approval · 2022-07-05FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE — Original Application (Neolpharma, Inc.)
FDA approved an original application for a generic product containing dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine…
-
FDA approval · 2022-06-23FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Original Application (Trigen Laboratories, LLC)
FDA approved methylphenidate hydrochloride from Trigen Laboratories, LLC under an Original Application. The product is indicated for attenti…
-
FDA approval · 2022-06-08FDA Approved: GUANFACINE HYDROCHLORIDE — Original Application (TWi Pharmaceuticals, Inc.)
FDA approved guanfacine hydrochloride as an Original Application (ANDA) submission by TWi Pharmaceuticals, Inc., establishing a generic vers…
-
FDA approval · 2022-06-01FDA Approved: DYANAVEL XR — Supplemental Application (NextWave Pharmaceuticals, Inc)
The FDA approved a supplemental application for DYANAVEL XR (amphetamine) from NextWave Pharmaceuticals. This action updates the product's l…
-
FDA approval · 2022-06-01FDA Approved: DYANAVEL XR — Supplemental Application (NextWave Pharmaceuticals, Inc)
The FDA approved a supplemental application for DYANAVEL XR (amphetamine) from NextWave Pharmaceuticals, authorizing changes to its labeling…
-
FDA approval · 2022-05-26FDA Approved: ATOMOXETINE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for atomoxetine by Dr. Reddy's Laboratories Limited, resulting in a new generic entry for ADHD treat…
-
FDA approval · 2022-04-29FDA Approved: QELBREE — Supplemental Application (Supernus Pharmaceuticals, Inc)
FDA approved a supplemental application for Qelbree (viloxazine hydrochloride) from Supernus Pharmaceuticals.